AKT1 and neoplasm: De-regulation of the MEK/ERK and especially the PI3K/Akt pathway are among the most frequent alterations associated to the generation of the tumour phenotype, as well as to the intrinsic or acquired resistance of tumour cells to anti-cancer treatments.